NCT03589768View on ClinicalTrials.gov

Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants

PHASE2CompletedINTERVENTIONAL
Enrollment

399

Participants

Timeline

Start Date

January 24, 2019

Primary Completion Date

July 1, 2020

Study Completion Date

July 1, 2020

Conditions
Clostridium Difficile ImmunisationDiphtheriaDiphtheria ImmunisationPertussisTetanusTetanus Immunisation
Interventions
BIOLOGICAL

Tetanus and Diphtheria Toxoids Adsorbed

Used for active immunization of adults and children 7 years of age and older against diphtheria and tetanus.

BIOLOGICAL

Tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine adsorbed onto aluminum hydroxide

A sterile isotonic suspension of tetanus and diphtheria toxoids and pertussis antigens adsorbed on Aluminum hydroxide.

Trial Locations (2)

21201-1509

University of Maryland, School of Medicine, Center for Vaccine Development and Global Health, Baltimore

Unknown

Center for Vaccine Development - Mali, Bamako

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT03589768 - Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants | Biotech Hunter | Biotech Hunter